Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (36 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jun 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Bandhan Large & Mid Cap Fund |
|---|---|
| 02 Jun 2008 | ₹100.00 |
| 08 Dec 2009 | ₹103.63 |
| 16 Jun 2011 | ₹106.62 |
| 21 Dec 2012 | ₹119.10 |
| 29 Jun 2014 | ₹142.95 |
| 04 Jan 2016 | ₹164.32 |
| 12 Jul 2017 | ₹224.06 |
| 17 Jan 2019 | ₹230.25 |
| 24 Jul 2020 | ₹214.55 |
| 30 Jan 2022 | ₹363.88 |
| 07 Aug 2023 | ₹449.14 |
| 12 Feb 2025 | ₹633.30 |
| 20 Aug 2026 | ₹752.57 |
| Metric | Bandhan · Regular NAV ₹141.92 Very High risk ★★★★☆ | Category median Large & Mid Cap Fund · 36 funds |
|---|---|---|
| +5.24% | +5.52% | |
| +18.73% | +14.91% | |
| +17.04% | +13.37% | |
| +15.08% | +14.19% | |
| +11.72% | +12.93% | |
| +16.59% | — | |
| +14.02% | +14.91% | |
| +13.78% | +14.70% | |
| +13.09% | +13.49% | |
| Risk | ||
| 14.28% | 14.80% | |
| 0.86 | 0.54 | |
| 1.16 | 0.73 | |
| -45.72% | -37.25% | |
| Nifty Midcap 150 | — | |
| +2.41% | -0.76% | |
| 0.85 | 0.83 | |
| 90.0% | 81.1% | |
| 74.5% | 81.1% | |
| 2.36% | 2.37% | |
| ₹19,777Cr | ₹3,576Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 18% | 42% | |
| Manish Gunwani · 3.6y | — | |
| 02 Jun 2008 | — | |
| 128 | — | |
| 26.7% | — | |
| 4.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.